the aid library

LIST OPTIONS

Filter

2597

Download (577)

View PDF (701)

Review of the national tuberculosis programme in Belarus

P. de Colombani World Health Organization Europe (2016) C_WHO

8–18 December 2015

External Link

Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen

R. Diel, B. Hauer, R. Loddenkemper, et al. (2009) C2

Recommendations for Tuberculosis Screening Before Initiation of TNF-α-Inhibitor Treatment in Rheumatic Diseases Diel R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren… Pneumologie 2009; 63: 329–334

Download (423)

View PDF (664)

Living Conditions among People with Activity Limitations in Malawi. A National Representative Study.

ME Loeb, Arne H Eide SINTEF Health Research (2004) C1

This research report provides results from the study on living conditions among people with disabilities in Malawi. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Malawi are also comp... more

Download (372)

View PDF (600)

UNICEF Yemen Country Office Humanitarian Situation Report (Reporting Period: 1 - 31 May 2020)

UN Children's Fund UNICEF (2020) C1

Download (513)

View PDF (657)

Forschung mit Weitblick - Ein Handbuch für Studierende mit Interesse an Global-Health-Forschung
recommended

Hommes F, Stratil J, Ströbele L, Bruchhausen W Global Health Alliance-Deutschland (GHA-D) (2019) CC

Eine wachsende Anzahl von Studierenden interessiert sich für Global Health. Bisher mangelt es jedoch an ausreichenden Angeboten zur Verwirklichung von studentischen Global-Health-Forschungsprojekten. Um vor diesem Hintergrund interessierte Studierende auf ihrem Weg zum eigenen Global-Health-Forschu... more

Download (331)

View PDF (334)

Morocco: Plan Stratégique national de prévention et de contrôle de la résistance aux antimicrobiens

Royaume du Maroc - Ministère de la Santè (2019) C_WHO

L’antibiorésistance constitue aujourd’hui l’un des grands défis à relever à l’échelle mondiale. Il s’agit d’une menace de santé publique majeure qui impose une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin d... more

External Link

Comprehensive COVID-19 Slideset: Special Populations and Comorbidities

Clinical Care Options (2021) CC

Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.

Download (341)

View PDF (454)

Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement

World Health Organization WHO (2022) C_WHO

Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij... more

Download (230)

View PDF (351)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (452)

View PDF (714)

Healthcare waste

USAID (2019) C1

Sector Environmental Guidelines, Full technical Update

Download (1025)

View PDF (1531)

LES ASPECTS ETHIQUES DE LA GYNÉCOLOGIE ET DEL’ OBSTÉTRIQUE Par le Comité de la FIGO pour l’Etudes des Problemes Éthiques en Reproduction Humaine

FIGO (2012) C2

'Ethical Issues in Obstetrics and Gynecology' represents the results of carefully researched and considered discussion. The guidelines are intended to provide material for consideration and debate about ethical aspects of our discipline for member organisations and their constituent membership.

Download (549)

View PDF (1365)

Invisible Wounds. The impact of six years of war on the mental health of Syria’s children

Save the Children (2017) C1

“The children are psychologically crushed and tired. When we do activities like singing with them, they don’t respond at all. They don’t laugh like they would normally. They draw images of children being butchered in the war, or tanks, or the siege and the lack of food.” Teacher in the... more

External Link

Transmission dynamics and control of Ebola virus disease (EVD): a review

Chowell and Nishiura (2014)

BMC Medicine 2014, 12:196 http://www.biomedcentral.com/1741-7015/12/196

External Link

Kenya Comprehensive Refugee Programme 2015

UN High Commissioner for Refugees (2015)

Download (334)

View PDF (461)

Ethical Decision-Making in Humanitarian Health in Situations of Extreme Violence. Report and Recommendations

Johns Hopkins Bloomberg School of Public Health , Syrian American Medical Society, et al. (2019) C1

Download (550)

View PDF (1151)

Save One Million Lives Program for Results

Nigeria, Federal Ministry of Health (2016) C1

Program Implementation Manual (PIM)
The Save One Million Lives Program for Results (SOML PforR) is a Federal Government of Nigeria maternal and child health program, supported by the World Bank, which provides incentives based on achievement of results (health outcomes) and helps to drive insti... more